Concepedia

Maarten Jacquemyn

MJ

Statistics

Publications

18

Citations

1.3K

H-Index

17

Active since

2015

Affiliations

Rega Institute for Medical Research(Current)

KU Leuven

Karyopharm Therapeutics (United States)

VIB-KU Leuven Center for Cancer Biology

Stanford University

Maarten Jacquemyn is an author at Rega Institute for Medical Research specializing in life sciences, molecular biology, and oncology.

ORCID

Publications per year

2015–2024

18

Publications

18

Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2

Jim Baggen, Leentje Persoons, Els Vanstreels et al. · Nature Genetics · 2021 · 236 citations · Full text

, , +14

TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry

Jim Baggen, Maarten Jacquemyn, Leentje Persoons et al. · Cell · 2023 · 163 citations · Full text

, , +17

Identifying Drug-Target Selectivity of Small-Molecule CRM1/XPO1 Inhibitors by CRISPR/Cas9 Genome Editing

Jasper E. Neggers, Thomas Vercruysse, Maarten Jacquemyn et al. · Chemistry & Biology · 2015 · 135 citations

, , +16

The material properties of a bacterial-derived biomolecular condensate tune biological function in natural and synthetic systems

Keren Lasker, Steven Boeynaems, Vinson Lam et al. · Nature Communications · 2022 · 132 citations · Full text

, , +17

Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genes

Jasper E. Neggers, Bert Kwanten, Tim Dierckx et al. · Nature Communications · 2018 · 105 citations · Full text

, , +17

1–5 of 18